CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

BACKGROUND. Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line,...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Goffart, Nicolas, Lombard, Arnaud, Lallemand, François, Kroonen, Jérôme, Nassen, Jessica, Di Valentin, Emmanuel, Berendsen, Sharon, Dedobbeleer, Matthias, Willems, Estelle, Robe, Pierre, Bours, Vincent, Martin, Didier, Martinive, Philippe, Maquet, Pierre, Rogister, Bernard
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2017
主題:
Basic and Translational Investigations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193023/
https://ncbi.nlm.nih.gov/pubmed/27370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now136
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料